ABCA1 Antibody [D20K13]

Catalog No.: F1630

    Application: Reactivity:
    • Lane 1: Mouse liver, Lane 2: Mouse liver (KO)
    1/

    当該製品は品切れ状态で、ごメールアドレスを教えていただければ、在庫があると、メールで顧客様に伝えます。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:200 - 1:500
    1:200
    1:1000-1:2000
    Application
    WB, IHC, FCM
    Source
    Mouse Monoclonal Antibody
    Reactivity
    Mouse, Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    254 kDa 254 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。

    Datasheet & SDS

    生物学的記述

    Specificity
    ABCA1 Antibody [D20K13] detects endogenous levels of total ABCA1 protein.
    Clone
    D20K13
    Synonym(s)
    ABC1; CERP; ABCA1; Phospholipid-transporting ATPase ABCA1; ATP-binding cassette sub-family A member 1; ATP-binding cassette transporter 1; Cholesterol efflux regulatory protein; ABC-1; ATP-binding cassette 1
    Background
    ATP binding cassette transporter A1 (ABCA1) is a large membrane transporter of the ABC family that uses ATP hydrolysis to export cellular cholesterol and phospholipids to lipid poor apolipoproteins, especially apoA I, thereby initiating nascent HDL formation and driving the first, rate limiting step of reverse cholesterol transport from peripheral tissues to the liver. ABCA1 is a protein comprising two six helix transmembrane domains that create a lipid translocation pathway, two cytosolic nucleotide binding domains with Walker A/B and LSGGQ signature motifs for ATP binding and hydrolysis, and two large, glycosylated extracellular domains unique to the ABCA subfamily that form a hydrophobic surface or tunnel for apoA I docking and lipid loading, with additional regulatory features such as a PEST sequence controlling proteolytic turnover and palmitoylated cysteines important for plasma membrane targeting. Cholesterol loading activates LXR/RXR, which upregulates ABCA1; at the plasma membrane and endosomes, ABCA1 undergoes ATP driven conformational cycling to mobilize phospholipids and free cholesterol from the inner leaflet and intracellular pools to the cell surface, where apoA I binding both stabilizes ABCA1 and captures these lipids to form discoidal nascent HDL, while concomitantly disrupting cholesterol rich lipid rafts and triggering JAK2/STAT3 and other signaling pathways that dampen inflammation and promote further efflux in macrophages. Through these transport and signaling functions, ABCA1 is essential for preventing foam cell formation and atherosclerosis and also contributes to β cell function, insulin secretion, and brain apoE lipidation and amyloid β handling; loss of function mutations in ABCA1 cause Tangier disease and familial HDL deficiency with near absent HDL and cholesterol ester accumulation, whereas more subtle defects in ABCA1 expression or activity increase cardiovascular and metabolic risk and may modulate susceptibility to late onset Alzheimer’s disease.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください